• Privacy Policy
  • Contacts
+39 085 295166 info@nsmcongressi.it
Haemosafety Haemosafety
  • Who we are
  • Topics
    • Emerging infections
    • Prion diseases
    • Viral infections: Epidemiology and treatment
    • Security in replacement therapy, pharmacovigilance and haemovigilance
    • Therapeutic advances
    • Zika Virus
  • Link
  • Subscribe to the newsletter
  • en
  • it
Home

Archive for Category: sicurezza terapia

Dec 16 2019

Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018

sicurezza terapia

In Italy, the use of nucleic acid testing for hepatitis B virus (HBV) in...

Read More

Nov 20 2019

Buffy coat-derived platelets cryopreserved using a new method: results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia

sicurezza terapia

The administration of cryopreserved platelets (PLTs) may overcome the limits of platelet shortage and...

Read More

Sep 17 2019

New Hemostatic Agents: Perioperative Anesthetic Considerations

sicurezza terapia

AIM: Pharmacologic agents with procoagulant effects and antidotes against antithrombotic drugs play an important...

Read More

May 16 2019

Risk factors for postoperative complications of orthopedic surgery in patients with hemophilia: Second report

sicurezza terapia

This study was conducted to investigate the incidence in patients with hemophilia of postoperative...

Read More

Feb 23 2019

Parvovirus B19: What Is the Relevance in Transfusion Medicine?

sicurezza terapia

Parvovirus B19 (B19V) has been discovered in 1975. The association with a disease was...

Read More

Feb 21 2019

Trasfusioni sangue effetti collaterali

Viral metagenomics and blood safety

sicurezza terapia

The characterization of the human blood-associated viral community (also called blood virome) is essential...

Read More

Feb 19 2019

Trasmissione virus Zika

Haematology patients and the risk of transfusion transmitted infection

sicurezza terapia

A 2014 study by NHS Blood and Transplant indicated that over one quarter of...

Read More

Feb 17 2019

Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high-purity plasma-derived factor X (pdFX) concentrate

sicurezza terapia

Hereditary factor X (FX) deficiency (FXD) is a rare autosomal recessive bleeding disorder with...

Read More

Feb 15 2019

False positive viral marker results in blood donors and their unintended consequences

sicurezza terapia

Universal donor screening for the major transfusion relevant viruses, hepatitis B virus (HBV), human...

Read More

Feb 13 2019

Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?

sicurezza terapia

Therapeutic factor VIII is highly immunogenic. Despite intensive research in the last decades, the...

Read More
Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Next
Copyright © 2021 Non Solo Meeting srl
CCIAA di Pescara n. 93080 - P.iva 01434640684 All Rights Reserved